Geode Capital Management’s BELLUS Health Inc. BLU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-116,395
Closed -$838K 4804
2023
Q1
$838K Buy
116,395
+3,135
+3% +$24.3K ﹤0.01% 3423
2022
Q4
$929K Hold
113,260
﹤0.01% 3378
2022
Q3
$1.2M Buy
113,260
+33,147
+41% +$352K ﹤0.01% 3302
2022
Q2
$738K Buy
80,113
+23,295
+41% +$191K ﹤0.01% 3556
2022
Q1
$390K Hold
56,818
﹤0.01% 4069
2021
Q4
$457K Hold
56,818
﹤0.01% 4104
2021
Q3
$348K Buy
56,818
+18,790
+49% +$71.3K ﹤0.01% 4194
2021
Q2
$118K Hold
38,028
﹤0.01% 4514
2021
Q1
$146K Buy
+38,028
New +$144K ﹤0.01% 4209
2020
Q4
Sell
-34,556
Closed -$78K 4298
2020
Q3
$78K Hold
34,556
﹤0.01% 3957
2020
Q2
$357K Buy
34,556
+13,529
+64% +$137K ﹤0.01% 3483
2020
Q1
$209K Buy
+21,027
New +$187K ﹤0.01% 3538

Other funds holding BLU

Geode Capital Management's BLU Position: Q2 2023 in Review

Geode Capital Management sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 116,395 shares — an estimated $838K sold.

Geode Capital Management first reported a position in BLU in Q1 2020 and held it in 12 quarters. The position peaked at $1.2M in Q3 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • Geode Capital Management reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • Geode Capital Management sold 116,395 BELLUS Health Inc. shares in Q2 2023, an estimated $838K.
  • Geode Capital Management first reported a position in BELLUS Health Inc. in Q1 2020 and held it in 12 quarters.
  • Geode Capital Management's BELLUS Health Inc. position peaked at $1.2M in Q3 2022.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Geode Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.